CIK 0001885522 · Non-accelerated filer<br>Smaller reporting company
Neumora Therapeutics, Inc.
Sign in to watch- Ticker
- NMRA
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 844367680
- Phone
- (857) 760-0900
- Business address
- 260 ARSENAL PLACE, SUITE 1, WATERTOWN, MA, 02472
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $481,506
- in 2 filings
Net −$481,506. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-05-28 | Pinto Joshua President | Grant or award · Stock Option (Right to Buy) | +223,034 | 223,034 | ||
| 2025-05-28 | Pinto Joshua President | Grant or award · Stock Option (Right to Buy) | +270,828 | 270,828 | ||
| 2025-05-28 | Pinto Joshua President | Grant or award · Stock Option (Right to Buy) | +223,034 | 223,034 | ||
| 2025-05-28 | Pinto Joshua President | Grant or award · Stock Option (Right to Buy) | +720,084 | 720,084 | ||
| 2025-05-28 | Pinto Joshua President | Grant or award · Stock Option (Right to Buy) | +127,448 | 127,448 | ||
| 2025-05-28 | Pinto Joshua President | Grant or award · Stock Option (Right to Buy) | +170,000 | 170,000 | ||
| 2025-05-28 | Pinto Joshua President | Grant or award · Stock Option (Right to Buy) | +3,000,000 | 3,000,000 | ||
| 2025-05-21 | Pinto Joshua President | Gift | −13,202 | 63,750 | ||
| 2025-05-21 | Pinto Joshua President | Gift | +13,202 | 152,167 | ||
| 2025-02-18 | BERNS PAUL L See Remarks | Sale 10b5-1 | −13,871 | $1.69 | $23K | 7,405,004 |
| 2025-02-18 | Milligan Michael Lee See Remarks | Sale 10b5-1 | −1,978 | $1.69 | $3K | 22,470 |
| 2025-02-18 | Aurora Daljit Singh Chief Strategy Officer | Sale 10b5-1 | −8,565 | $1.68 | $14K | 88,935 |
| 2025-02-18 | Lenz Robert A. Head of R&D | Sale 10b5-1 | −5,614 | $1.67 | $9K | 309,092 |
| 2025-02-18 | Pinto Joshua President | Sale 10b5-1 | −8,048 | $1.67 | $13K | 76,952 |
| 2025-02-13 | Ho Maykin Director | Returned to the company · Stock Option (Right to Buy) | −95,586 | 0 | ||
| 2025-02-13 | Ho Maykin Director | Returned to the company · Stock Option (Right to Buy) | −27,802 | 0 | ||
| 2025-02-13 | Ho Maykin Director | Returned to the company · Stock Option (Right to Buy) | −28,571 | 0 | ||
| 2025-02-13 | Ho Maykin Director | Grant or award · Stock Option (Right to Buy) | +95,586 | 95,586 | ||
| 2025-02-13 | Ho Maykin Director | Grant or award · Stock Option (Right to Buy) | +27,802 | 27,802 | ||
| 2025-02-13 | Ho Maykin Director | Grant or award · Stock Option (Right to Buy) | +28,571 | 28,571 |
Page 8 of 20 · 384 trades